Symmetry Medical, Inc. (SMA) Reports Q4 EPS of $0.05

Symmetry Medical, Inc. (NYSE: SMA) reported Q4 EPS of $0.05. Revenue for the quarter came in at $78.45 million.

For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.

You May Also Be Interested In

• Citi raises Atlassian price target to $225, maintains Buy rating
• Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy
• RBC Capital Downgrades GQG Partners Inc (GQG:AU) to Sector Perform